Terms: = Prostate cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
5 results:
1. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract] [Full Text] [Related]
2. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
3. Mesenchymal stromal cell secretome up-regulates 47 kDa cxcr4 expression, and induce invasiveness in neuroblastoma cell lines.
Shankar V; Hori H; Kihira K; Lei Q; Toyoda H; Iwamoto S; Komada Y
PLoS One; 2015; 10(3):e0120069. PubMed ID: 25774696
[TBL] [Abstract] [Full Text] [Related]
4. CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
Kerr BA; Miocinovic R; Smith AK; West XZ; Watts KE; Alzayed AW; Klink JC; Mir MC; Sturey T; Hansel DE; Heston WD; Stephenson AJ; Klein EA; Byzova TV
Oncotarget; 2015 Jan; 6(3):1889-97. PubMed ID: 25595903
[TBL] [Abstract] [Full Text] [Related]
5. [cxcr4 combined with P504S or P63 in differential diagnosis of benign and malignant prostatic diseases].
Qu F; Xing YF; Xiao YJ; Xiao CG; Guo HQ
Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1059-62. PubMed ID: 19157222
[TBL] [Abstract] [Full Text] [Related]
